Blood sugar targets during heart surgery in older adults with diabetes
Part of Heart & circulation, Hormones & metabolism clinical trials.
This trial tests how tightly blood sugar should be controlled during heart surgery for patients aged 60 and older with type 2 diabetes. It may help reduce complications and improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 60 years old or older.
- You have type 2 diabetes and have been taking diabetes medication for at least 3 months before surgery.
- You are scheduled for elective heart surgery using a heart-lung machine (cardiopulmonary bypass).
- Your surgery involves at least two heart procedures, such as bypass, valve repair, or others.
- You are able to provide written consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks if monitoring and treating blood sugar levels during long surgeries can lower the risk of infections and other problems afterward. It is for adults having any surgery expected to last 2 hours or more.
This study checks how common high blood sugar is during and after surgery in people with pre-diabetes, which may help improve care for future patients.
This study looks at how well-controlled blood sugar (measured by HbA1c) affects brain oxygen levels during urologic surgery and how it impacts recovery afterward. It compares diabetic patients to non-diabetic patients to understand the role of blood sugar control in surgical outcomes.
This trial tests a smart insulin pump system (hybrid closed-loop) to control blood sugar in people with type 2 diabetes who need surgery and will receive nutrition through a vein. It aims to prevent high and low blood sugar during and after surgery.
This study tests whether carefully managing blood sugar levels after planned brain surgery can reduce the risk of surgical site infections. Researchers will monitor and control glucose (blood sugar) in the period right after surgery to see if it helps patients heal better.
This trial tests whether patients with heart failure having heart surgery should stop taking their SGLT-2 inhibitor (like empagliflozin or dapagliflozin) or keep taking it, to see which is safer and better.
Hear when a new Glycemic Management During CPB in Elderly Diabetic Cardiac Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.